Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 50

1.

Host-directed therapies for infectious diseases: current status, recent progress, and future prospects.

Zumla A, Rao M, Wallis RS, Kaufmann SH, Rustomjee R, Mwaba P, Vilaplana C, Yeboah-Manu D, Chakaya J, Ippolito G, Azhar E, Hoelscher M, Maeurer M; Host-Directed Therapies Network consortium.

Lancet Infect Dis. 2016 Apr;16(4):e47-63. doi: 10.1016/S1473-3099(16)00078-5. Review.

PMID:
27036359
2.

Tuberculosis--advances in development of new drugs, treatment regimens, host-directed therapies, and biomarkers.

Wallis RS, Maeurer M, Mwaba P, Chakaya J, Rustomjee R, Migliori GB, Marais B, Schito M, Churchyard G, Swaminathan S, Hoelscher M, Zumla A.

Lancet Infect Dis. 2016 Apr;16(4):e34-46. doi: 10.1016/S1473-3099(16)00070-0. Review.

PMID:
27036358
3.

World TB Day 2016: reflections on the global TB emergency.

Zumla A, Schito M, Chakaya J, Marais B, Mwaba P, Migliori GB, Hoelscher M, Maeurer M, Wallis RS.

Lancet Respir Med. 2016 Apr;4(4):249-51. doi: 10.1016/S2213-2600(16)00066-7. Epub 2016 Mar 23. No abstract available.

PMID:
27016869
4.

Taking forward the World TB Day 2016 theme 'Unite to End Tuberculosis' for the WHO Africa Region.

Ntoumi F, Kaleebu P, Macete E, Mfinanga S, Chakaya J, Yeboah-Manu D, Bates M, Mwaba P, Maeurer M, Petersen E, Zumla A.

Int J Infect Dis. 2016 May;46:34-7. doi: 10.1016/j.ijid.2016.03.003. Epub 2016 Mar 8.

5.

Translational Research for Tuberculosis Elimination: Priorities, Challenges, and Actions.

Lienhardt C, Lönnroth K, Menzies D, Balasegaram M, Chakaya J, Cobelens F, Cohn J, Denkinger CM, Evans TG, Källenius G, Kaplan G, Kumar AM, Matthiessen L, Mgone CS, Mizrahi V, Mukadi YD, Nguyen VN, Nordström A, Sizemore CF, Spigelman M, Squire SB, Swaminathan S, Van Helden PD, Zumla A, Weyer K, Weil D, Raviglione M.

PLoS Med. 2016 Mar 2;13(3):e1001965. doi: 10.1371/journal.pmed.1001965. eCollection 2016 Mar. Review. No abstract available.

6.

Host-Directed Therapies for Tackling Multi-Drug Resistant Tuberculosis: Learning From the Pasteur-Bechamp Debates.

Zumla A, Maeurer M; Host-Directed Therapies Network (HDT-NET) Consortium.

Clin Infect Dis. 2015 Nov 1;61(9):1432-8. doi: 10.1093/cid/civ631. Epub 2015 Jul 28.

PMID:
26219693
7.

Towards host-directed therapies for tuberculosis.

Zumla A, Maeurer M; Host-Directed Therapies Network, Chakaya J, Hoelscher M, Ntoumi F, Rustomjee R, Vilaplana C, Yeboah-Manu D, Rasolof V, Munderi P, Singh N, Aklillu E, Padayatchi N, Macete E, Kapata N, Mulenga M, Kibiki G, Mfinanga S, Nyirenda T, Maboko L, Garcia-Basteiro A, Rakotosamimanana N, Bates M, Mwaba P, Reither K, Gagneux S, Edwards S, Mfinanga E, Abdulla S, Cardona PJ, Russell JB, Gant V, Noursadeghi M, Elkington P, Bonnet M, Menendez C, Dieye TN, Diarra B, Maiga A, Aseffa A, Parida S, Wejse C, Petersen E, Kaleebu P, Oliver M, Craig G, Corrah T, Tientcheu L, Antonio M, Rao M, McHugh TD, Sheikh A, Ippolito G, Ramjee G, Kaufmann SH, Churchyard G, Steyn A, Grobusch M, Sanne I, Martinson N, Madansein R, Wilkinson RJ, Mayosi B, Schito M, Wallis RS.

Nat Rev Drug Discov. 2015 Aug;14(8):511-2. doi: 10.1038/nrd4696. Epub 2015 Jul 17.

PMID:
26184493
8.
9.

Commemorating World Tuberculosis Day 2015.

Zumla A, Maeurer M, Marais B, Chakaya J, Wejse C, Lipman M, McHugh TD, Petersen E.

Int J Infect Dis. 2015 Mar;32:1-4. doi: 10.1016/j.ijid.2015.01.009. No abstract available.

10.

Tuberculosis treatment and management--an update on treatment regimens, trials, new drugs, and adjunct therapies.

Zumla A, Chakaya J, Centis R, D'Ambrosio L, Mwaba P, Bates M, Kapata N, Nyirenda T, Chanda D, Mfinanga S, Hoelscher M, Maeurer M, Migliori GB.

Lancet Respir Med. 2015 Mar;3(3):220-34. doi: 10.1016/S2213-2600(15)00063-6. Epub 2015 Mar 9. Review.

PMID:
25773212
11.

Pulmonary specialty training to improve respiratory health in low- and middle-income countries. Needs and challenges.

Chakaya JM, Carter EJ, Hopewell PC.

Ann Am Thorac Soc. 2015 Apr;12(4):486-90. doi: 10.1513/AnnalsATS.201502-071PS.

PMID:
25714500
12.

Is introducing rapid culture into the diagnostic algorithm of smear-negative tuberculosis cost-effective?

Yakhelef N, Audibert M, Varaine F, Chakaya J, Sitienei J, Huerga H, Bonnet M.

Int J Tuberc Lung Dis. 2014 May;18(5):541-6. doi: 10.5588/ijtld.13.0630.

PMID:
24903790
13.

Quality tuberculosis care. All should adopt the new international standards for tuberculosis care.

Chakaya J, Raviglione M.

Ann Am Thorac Soc. 2014 Mar;11(3):397-8. doi: 10.1513/AnnalsATS.201401-014ED. No abstract available.

PMID:
24673693
14.

Tuberculosis treatment outcomes among hospital workers at a public teaching and national referral hospital in Kenya.

Wahome E, Makori L, Gikera M, Wafula J, Chakaya J, Edginton ME, Kumar AM.

Public Health Action. 2013 Dec 21;3(4):323-7. doi: 10.5588/pha.13.0054.

15.

Exploring mechanisms of excess mortality with early fluid resuscitation: insights from the FEAST trial.

Maitland K, George EC, Evans JA, Kiguli S, Olupot-Olupot P, Akech SO, Opoka RO, Engoru C, Nyeko R, Mtove G, Reyburn H, Brent B, Nteziyaremye J, Mpoya A, Prevatt N, Dambisya CM, Semakula D, Ddungu A, Okuuny V, Wokulira R, Timbwa M, Otii B, Levin M, Crawley J, Babiker AG, Gibb DM; FEAST trial group.

BMC Med. 2013 Mar 14;11:68. doi: 10.1186/1741-7015-11-68.

16.

Performance of the 2007 WHO algorithm to diagnose smear-negative pulmonary tuberculosis in a HIV prevalent setting.

Huerga H, Varaine F, Okwaro E, Bastard M, Ardizzoni E, Sitienei J, Chakaya J, Bonnet M.

PLoS One. 2012;7(12):e51336. doi: 10.1371/journal.pone.0051336. Epub 2012 Dec 19.

17.

Scaling up interventions to achieve global tuberculosis control: progress and new developments.

Raviglione M, Marais B, Floyd K, Lönnroth K, Getahun H, Migliori GB, Harries AD, Nunn P, Lienhardt C, Graham S, Chakaya J, Weyer K, Cole S, Kaufmann SH, Zumla A.

Lancet. 2012 May 19;379(9829):1902-13. doi: 10.1016/S0140-6736(12)60727-2. Review. Erratum in: Lancet. 2012 Jun 16;379(9833):2242.

PMID:
22608339
18.

Tuberculosis diagnostics and biomarkers: needs, challenges, recent advances, and opportunities.

McNerney R, Maeurer M, Abubakar I, Marais B, McHugh TD, Ford N, Weyer K, Lawn S, Grobusch MP, Memish Z, Squire SB, Pantaleo G, Chakaya J, Casenghi M, Migliori GB, Mwaba P, Zijenah L, Hoelscher M, Cox H, Swaminathan S, Kim PS, Schito M, Harari A, Bates M, Schwank S, O'Grady J, Pletschette M, Ditui L, Atun R, Zumla A.

J Infect Dis. 2012 May 15;205 Suppl 2:S147-58. doi: 10.1093/infdis/jir860. Epub 2012 Apr 10. Review.

PMID:
22496353
19.

Drug-resistant tuberculosis--current dilemmas, unanswered questions, challenges, and priority needs.

Zumla A, Abubakar I, Raviglione M, Hoelscher M, Ditiu L, McHugh TD, Squire SB, Cox H, Ford N, McNerney R, Marais B, Grobusch M, Lawn SD, Migliori GB, Mwaba P, O'Grady J, Pletschette M, Ramsay A, Chakaya J, Schito M, Swaminathan S, Memish Z, Maeurer M, Atun R.

J Infect Dis. 2012 May 15;205 Suppl 2:S228-40. doi: 10.1093/infdis/jir858. Epub 2012 Apr 3.

PMID:
22476720
20.

Adherence to self-administered tuberculosis treatment in a high HIV-prevalence setting: a cross-sectional survey in Homa Bay, Kenya.

Nackers F, Huerga H, Espié E, Aloo AO, Bastard M, Etard JF, Sitienei J, Varaine F, Chakaya J, Bonnet M.

PLoS One. 2012;7(3):e32140. doi: 10.1371/journal.pone.0032140. Epub 2012 Mar 12.

Supplemental Content

Loading ...
Support Center